GLP-1 (glucagon-like peptide-1) injection pens are medical devices used to administer medications that mimic the action of the naturally occurring hormone GLP-1.
The global Electronic Smart Injection Pen market is projected to reach US$ 710.1 million in 2029, increasing from US$ 536 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2029.
Key manufacturers engaged in the Electronic Smart Injection Pen industry include Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Tonghua Dongbao Pharmaceutical, Owen Mumford, Gan&Lee Pharmaceuticals and Jiangsu Delfu medical devices, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Electronic Smart Injection Pen were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Electronic Smart Injection Pen market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Electronic Smart Injection Pen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Tonghua Dongbao Pharmaceutical
Owen Mumford
Gan&Lee Pharmaceuticals
Jiangsu Delfu medical devices
Hanerxi Medical
Segment by Type
Variable Dose
Fixed Dose
Segment by Application
Diabetes
Obesity
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Electronic Smart Injection Pen report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Electronic Smart Injection Pen Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Electronic Smart Injection Pen
1.2 Electronic Smart Injection Pen Segment by Type
1.2.1 Global Electronic Smart Injection Pen Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Variable Dose
1.2.3 Fixed Dose
1.3 Electronic Smart Injection Pen Segment by Application
1.3.1 Global Electronic Smart Injection Pen Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Diabetes
1.3.3 Obesity
1.3.4 Other
1.4 Global Electronic Smart Injection Pen Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Electronic Smart Injection Pen Revenue 2018-2029
1.4.2 Global Electronic Smart Injection Pen Sales 2018-2029
1.4.3 Global Electronic Smart Injection Pen Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Electronic Smart Injection Pen Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Electronic Smart Injection Pen Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Electronic Smart Injection Pen Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Electronic Smart Injection Pen Average Price by Manufacturers (2018-2023)
2.4 Global Electronic Smart Injection Pen Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Electronic Smart Injection Pen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Electronic Smart Injection Pen, Product Type & Application
2.7 Electronic Smart Injection Pen Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Electronic Smart Injection Pen Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Electronic Smart Injection Pen Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Electronic Smart Injection Pen Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Electronic Smart Injection Pen Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Electronic Smart Injection Pen Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Electronic Smart Injection Pen Global Electronic Smart Injection Pen Sales by Region: 2018-2029
3.2.1 Global Electronic Smart Injection Pen Sales by Region: 2018-2023
3.2.2 Global Electronic Smart Injection Pen Sales by Region: 2024-2029
3.3 Global Electronic Smart Injection Pen Global Electronic Smart Injection Pen Revenue by Region: 2018-2029
3.3.1 Global Electronic Smart Injection Pen Revenue by Region: 2018-2023
3.3.2 Global Electronic Smart Injection Pen Revenue by Region: 2024-2029
3.4 North America Electronic Smart Injection Pen Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Electronic Smart Injection Pen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Electronic Smart Injection Pen Sales by Country (2018-2029)
3.4.3 North America Electronic Smart Injection Pen Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Electronic Smart Injection Pen Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Electronic Smart Injection Pen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Electronic Smart Injection Pen Sales by Country (2018-2029)
3.5.3 Europe Electronic Smart Injection Pen Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Electronic Smart Injection Pen Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Electronic Smart Injection Pen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Electronic Smart Injection Pen Sales by Country (2018-2029)
3.6.3 Asia Pacific Electronic Smart Injection Pen Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Electronic Smart Injection Pen Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Electronic Smart Injection Pen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Electronic Smart Injection Pen Sales by Country (2018-2029)
3.7.3 Latin America Electronic Smart Injection Pen Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Electronic Smart Injection Pen Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Electronic Smart Injection Pen Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Electronic Smart Injection Pen Sales by Country (2018-2029)
3.8.3 Middle East and Africa Electronic Smart Injection Pen Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Electronic Smart Injection Pen Sales by Type (2018-2029)
4.1.1 Global Electronic Smart Injection Pen Sales by Type (2018-2023)
4.1.2 Global Electronic Smart Injection Pen Sales by Type (2024-2029)
4.1.3 Global Electronic Smart Injection Pen Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Electronic Smart Injection Pen Revenue by Type (2018-2029)
4.2.1 Global Electronic Smart Injection Pen Revenue by Type (2018-2023)
4.2.2 Global Electronic Smart Injection Pen Revenue by Type (2024-2029)
4.2.3 Global Electronic Smart Injection Pen Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Electronic Smart Injection Pen Price by Type (2018-2029)
5 Segment by Application
5.1 Global Electronic Smart Injection Pen Sales by Application (2018-2029)
5.1.1 Global Electronic Smart Injection Pen Sales by Application (2018-2023)
5.1.2 Global Electronic Smart Injection Pen Sales by Application (2024-2029)
5.1.3 Global Electronic Smart Injection Pen Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Electronic Smart Injection Pen Revenue by Application (2018-2029)
5.2.1 Global Electronic Smart Injection Pen Revenue by Application (2018-2023)
5.2.2 Global Electronic Smart Injection Pen Revenue by Application (2024-2029)
5.2.3 Global Electronic Smart Injection Pen Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Electronic Smart Injection Pen Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk Electronic Smart Injection Pen Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly Electronic Smart Injection Pen Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Electronic Smart Injection Pen Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Electronic Smart Injection Pen Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Ypsomed Holding
6.5.1 Ypsomed Holding Corporation Information
6.5.2 Ypsomed Holding Description and Business Overview
6.5.3 Ypsomed Holding Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ypsomed Holding Electronic Smart Injection Pen Product Portfolio
6.5.5 Ypsomed Holding Recent Developments/Updates
6.6 Tonghua Dongbao Pharmaceutical
6.6.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.6.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.6.3 Tonghua Dongbao Pharmaceutical Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tonghua Dongbao Pharmaceutical Electronic Smart Injection Pen Product Portfolio
6.6.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.7 Owen Mumford
6.6.1 Owen Mumford Corporation Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Owen Mumford Electronic Smart Injection Pen Product Portfolio
6.7.5 Owen Mumford Recent Developments/Updates
6.8 Gan&Lee Pharmaceuticals
6.8.1 Gan&Lee Pharmaceuticals Corporation Information
6.8.2 Gan&Lee Pharmaceuticals Description and Business Overview
6.8.3 Gan&Lee Pharmaceuticals Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Gan&Lee Pharmaceuticals Electronic Smart Injection Pen Product Portfolio
6.8.5 Gan&Lee Pharmaceuticals Recent Developments/Updates
6.9 Jiangsu Delfu medical devices
6.9.1 Jiangsu Delfu medical devices Corporation Information
6.9.2 Jiangsu Delfu medical devices Description and Business Overview
6.9.3 Jiangsu Delfu medical devices Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jiangsu Delfu medical devices Electronic Smart Injection Pen Product Portfolio
6.9.5 Jiangsu Delfu medical devices Recent Developments/Updates
6.10 Hanerxi Medical
6.10.1 Hanerxi Medical Corporation Information
6.10.2 Hanerxi Medical Description and Business Overview
6.10.3 Hanerxi Medical Electronic Smart Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hanerxi Medical Electronic Smart Injection Pen Product Portfolio
6.10.5 Hanerxi Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Electronic Smart Injection Pen Industry Chain Analysis
7.2 Electronic Smart Injection Pen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Electronic Smart Injection Pen Production Mode & Process
7.4 Electronic Smart Injection Pen Sales and Âé¶¹Ô´´ing
7.4.1 Electronic Smart Injection Pen Sales Channels
7.4.2 Electronic Smart Injection Pen Distributors
7.5 Electronic Smart Injection Pen Customers
8 Electronic Smart Injection Pen Âé¶¹Ô´´ Dynamics
8.1 Electronic Smart Injection Pen Industry Trends
8.2 Electronic Smart Injection Pen Âé¶¹Ô´´ Drivers
8.3 Electronic Smart Injection Pen Âé¶¹Ô´´ Challenges
8.4 Electronic Smart Injection Pen Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Tonghua Dongbao Pharmaceutical
Owen Mumford
Gan&Lee Pharmaceuticals
Jiangsu Delfu medical devices
Hanerxi Medical
Ìý
Ìý
*If Applicable.